Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

Elsa Bernard, Heinz Tuechler, Peter L. Greenberg, Robert P. Hasserjian, Juan Arango Ossa, Yasuhito Nannya, Sean M. Devlin, Maria Creignou, Philippe Pinel, Lily Monnier, Gunes Gundem, Juan S. Medina-Martínez, Dylan Domenico, Martin Jädersten, Ulrich Germing, Guillermo Sanz, Arjan A. van de Loosdrecht, Olivier Kosmider, Matilde Y. Follo, Felicitas Thol, Lurdes Zamora, Ronald Feitosa Pinheiro, Andrea Pellagatti, Harold K. Elias, Detlef Haase, Christina Ganster, Lionel Adès, Magnus Tobiasson, Laura Palomo, Matteo Giovanni Della Porta, Akifumi Takaori‐Kondo, Takayuki Ishikawa, Shigeru Chiba, Senji Kasahara, Yasushi Miyazaki, Agnès Viale, Kety Huberman, Pierre Fenaux, Monika Beličková, Michael R. Savona, Virginia M. Klimek, Fábio Pires de Souza Santos, Jacqueline Boultwood, Ιoannis Kotsianidis, Valeria Santini, Françesc Solé, Uwe Platzbecker, Michael Heuser, Peter Valent, Kazuma Ohyashiki, Carlo Finelli, Maria Teresa Voso, Lee‐Yung Shih, Michaëla Fontenay, Joop H. Jansen, José Cervera, Norbert Gattermann, Benjamin L. Ebert, Rafael Bejar, Luca Malcovati, Mario Cazzola, Seishi Ogawa, Eva Hellström‐Lindberg, Elli Papaemmanuil

NEJM Evidence, 2022

Memorial Sloan Kettering Cancer Center, Stanford University, Massachusetts General Hospital, The University of Tokyo, Kyoto University, Karolinska Institutet, Karolinska University Hospital, Heinrich Heine University Düsseldorf, Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, Leitat Technological Center, Hospital Universitari i Politècnic La Fe, University Medical Center, Université Paris Cité, Délégation Paris 5, Assistance Publique – Hôpitaux de Paris, Hôpital Cochin, University of Bologna, Medizinische Hochschule Hannover, Josep Carreras Leukaemia Research Institute, Institut Català d'Oncologia, Universidade Federal do Ceará, Oxford BioMedica (United Kingdom), University of Oxford, Universitätsmedizin Göttingen, Fundación Josep Carreras Contra la Leucemia, Humanitas University, Kobe City Medical Center General Hospital, University of Tsukuba, Gifu Municipal Hospital, Nagasaki University, Igenbio (United States), Institute of Haematology and Blood Transfusion, Vanderbilt University, Hospital Israelita Albert Einstein, Democritus University of Thrace, University of Florence, Azienda Ospedaliero-Universitaria Careggi, University Hospital Leipzig, Medical University of Vienna, Tokyo Medical University, Istituti di Ricovero e Cura a Carattere Scientifico, Chang Gung University, Linkou Chang Gung Memorial Hospital, Radboud University Medical Center, Radboud University Nijmegen, Howard Hughes Medical Institute, University of California, San Diego, University of Pavia

View Free PDF Publisher Website

Abstract

This research paper explore the methodology and findings associated with NEJM Evidence. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

780

Citations

View on Google Scholar

Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

Abstract

Journal Details

Join JournalsHub

Welcome Back